Diana Bellavia


Titolo Pubblicato in Anno
Loss of ATP2C1 function promotes trafficking and degradation of NOTCH1: Implications for Hailey-Hailey disease EXPERIMENTAL DERMATOLOGY 2023
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance FRONTIERS IN ONCOLOGY 2022
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL CANCERS 2022
When viruses cross developmental pathways FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 2021
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy CANCERS 2021
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response ONCOGENESIS 2020
A dynamic role of mastermind-like 1: a journey through the main (path)ways between development and cancer FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 2020
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer CANCERS 2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells STEM CELLS INTERNATIONAL 2019
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL FRONTIERS IN ONCOLOGY 2019
Notch/CXCR4 partnership in acute lymphoblastic leukemia progression JOURNAL OF IMMUNOLOGY RESEARCH 2019
Notch signaling activation as a hallmark for triple-negative breast cancer subtype JOURNAL OF ONCOLOGY 2019
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP NATURE COMMUNICATIONS 2019
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer FRONTIERS IN GENETICS 2019
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance CANCER RESEARCH 2019
PLK1 targets NOTCH1 during DNA damage and mitotic progression THE JOURNAL OF BIOLOGICAL CHEMISTRY 2019
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response The Biennial Congress of the Italian Association of cell biology and differentiation 2019
Notch/{CXCR}4 Partnership in Acute Lymphoblastic Leukemia Progression JOURNAL OF IMMUNOLOGY RESEARCH 2019
Notch signaling as a therapeutic target for acute lymphoblastic leukemia EXPERT OPINION ON THERAPEUTIC TARGETS 2018
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Atti del ABCD - PPh.D. meeting 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma